Allogene Therapeutics
ALLO
ALLO
95 hedge funds and large institutions have $1.87B invested in Allogene Therapeutics in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $1.85B → $1.87B (+$22.8M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.25% less ownership
Funds ownership: 56.67% → 56.42% (-0.25%)
Holders
95
Holding in Top 10
4
Calls
$10.7M
Puts
$2.28M
Top Buyers
| 1 | +$13.8M | |
| 2 | +$13.7M | |
| 3 | +$12M | |
| 4 |
WCM
Wildcat Capital Management
New York
|
+$10.2M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$7.51M |
Top Sellers
| 1 | -$49M | |
| 2 | -$9.02M | |
| 3 | -$7.07M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$6.42M |
| 5 |
DP
DSAM Partners
London,
United Kingdom
|
-$4.33M |